Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Is The Asthma Treatment Market Expected To Grow In Terms Of Size?
The market for asthma treatments has seen constant growth over the past years. The size of the market is set to expand from $22.69 billion in 2024 to $23.75 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 4.7%. The observed expansion during the historic period can be credited to factors such as increasing urbanization and pollution, the growing use of inhalers and nebulizers, improved healthcare accessibility in emerging economies, and the rise in awareness, diagnoses, and exposure to allergens.
The market for asthma treatment is projected to experience consistent expansion in the forthcoming years. It is predicted to reach $28.27 billion by 2029, with a Compound Annual Growth Rate (CAGR) of 4.5%. Various factors, such as evolving emphasis on individualized asthma therapies, increased acceptance of biologics and monoclonal antibodies, larger investment in research and development of respiratory medications, rising use of telehealth and digital tools for asthma management, and expanding government initiatives for chronic respiratory care, contribute to the growth during the forecast period. The period is likely to see some key trends such as progress in biologic therapies for severe asthma, high-tech digital inhalers with tracking capabilities, the evolution of personalized medicine strategies, breakthroughs in drug-delivery technology, and advancement in AI-assisted asthma management platforms.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25703&type=smp
What Market Forces Are Contributing To The Growth Of The Asthma Treatment Market?
An anticipated growth in the asthma treatment market is linked directly to the growing occurrence of respiratory issues. These pertained health problems encompass ailments that impact the lungs and interfere with breathing, such as chronic obstructive pulmonary disease (COPD), bronchitis, and asthma. One significant contributor to the escalation of these respiratory illnesses is air pollution, mainly due to particulate matter and nitrogen oxides, which inflame and irritate the airways, causing difficulty in breathing and exacerbating conditions like asthma. This upward trend in respiratory disorders amplifies the need for asthma treatments that generally involve medication, inhalers, and lifestyle amendments focused on managing airway inflammation and associated symptoms. As an example, in December 2023, data from the National Library of Medicine, a US national library, projected that by 2050, COPD instances in low- and middle-income countries would exceed double the cases in the wealthier countries. Sub-Saharan Africa would account for a 59% rise and would have the highest rank in global chronic obstructive pulmonary disease (COPD) prevalence and cases by 2040. Consequently, the escalating occurrence of respiratory ailments is fuelling the expansion of the asthma treatment market.
How Is The Asthma Treatment Market Segmented Across Key Categories?
The asthma treatment market covered in this report is segmented –
1) By Treatment: Long-Term Control Medications, Quick-Relief Medications
2) By Device Type: Inhalers, Dry Powder, Metered Dose, Soft Mist Nebulizers
3) By Drug Class: Short-Acting Beta-Agonists (SABA), Long-Acting Beta-Agonists (LABA), Inhaled Corticosteroids (ICS), Leukotriene Modifiers, Immunomodulators, Combination Drugs, Other Drug Class
4) By Route Of Administration: Oral, Inhaled, Intravenous, Subcutaneous
5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
Subsegments:
1) By Long-Term Control Medications: Inhaled Corticosteroids (ICS), Long-Acting Beta-Agonists (LABA), Leukotriene Receptor Antagonists (LTRA), Long-Acting Muscarinic Antagonists (LAMA), Methylxanthines, Biologics
2) By Quick-Relief Medications: Short-Acting Beta-Agonists (SABA), Systemic Corticosteroids, Anticholinergics
What Key Trends Are Driving Growth In The Asthma Treatment Market?
In the asthma treatment market, leading businesses are prioritizing the creation of innovative products, like anti-inflammatory rescue inhalers, which offer quick relief to symptoms and target the foundational airway inflammation found in asthma patients. These inhalers act to alleviate immediate asthma symptoms (rescue function) all while lessening the airway inflammation (anti-inflammatory action) during an asthma attack. For instance, AstraZeneca, a biopharmaceutical company based in the UK, introduced AIRSUPRA (albuterol/budesonide), a groundbreaking inhaler for asthma treatment, in January 2024. It stands as the first and only FDA-approved fixed-dose blend of albuterol, a short-acting beta2-agonist (SABA), and budesonide, an inhaled corticosteroid (ICS), crafted to operate as a rescue medication for asthma. It provides immediate bronchodilation and concurrently addresses airway inflammation during asthma flare-ups, tackling both symptoms and inherent inflammation with one inhalation. The inhaler is aimed at patients aged 18 years and older and promotes improved overall control of asthma while decreasing dependency on separate controller medications.
Who Are The Major Stakeholders Operating In The Asthma Treatment Market?
Major companies operating in the asthma treatment market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., AstraZeneca PLC, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Amgen Inc., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Limited, Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Genentech Inc., Sumitomo Pharma Co Ltd., Chiesi Farmaceutici S.p.A., Cipla Limited.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/asthma-treatment-global-market-report
How Do Regional Dynamics Influence The Asthma Treatment Market Performance?
North America was the largest region in the asthma treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the asthma treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=25703&type=smp
Browse Through More Reports Similar to the Global Asthma Treatment Market 2025, By The Business Research Company
Asthma Spacers Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/asthma-spacers-global-market-report
Allergy Treatment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/allergy-treatment-global-market-report
Bronchitis Treatment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/bronchitis-treatment-global-market-report
About The Business Research Company:
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
